You can purchase 2T and 40T packs of ImmuView® COVID-19 Ag Home Test on Amazon. The ImmuView® COVID-19 Antigen Home Test is intended for the detection of SARS-CoV-2 (the virus that causes COVID-19). This self-administered test is for individuals ages 14 years and older. Adult-collection is required for testing children ages 2-13 years old. EASY TO USE AND QUICK RESULTS:.... Read Full Article >
The U.S. FDA has granted Emergency Use Authorization for CTK Biotech’s ImmuView® COVID-19 Antigen Home Test On December 20th, CTK Biotech obtained the FDA’s Emergency Use Authorization for their ImmuView® COVID-19 Antigen Home Test, a few months after being the first to receive the WHO Emergency Use Listing for their international brand, OnSite® COVID-19 Ag Self Test. The FDA EUA.... Read Full Article >
On July 18th 2022, CTK Biotech’s OnSite® COVID-19 Ag Self Test received WHO Emergency Use Listing for meeting WHO’s quality, safety, and performance requirements. CTK’s COVID-19 Ag Self Test is the first in the market to receive this Pre-Qualification. This milestone accomplishment reflects CTK’s 20-plus years of experience in providing best-in-class products across the globe. Read more about the WHO’s.... Read Full Article >
The Philippines FDA has granted approval of the CTK’s OnSite COVID-19 Ag Self-Test for its high quality and excellent performance.
We’re pleased to announce that CTK’s Onsite COVID-19 Ag Rapid Test has been granted WHO Emergency Use Listing! The OnSite COVID-19 Ag Rapid Test is deemed to meet WHO quality, safety, and performance requirements and is now eligible for relevant procurement agencies and the Member States. To learn more about CTK’s OnSite COVID-19 Ag Rapid Test
CTK Biotech is proud to announce that the OnSite Dengue IgG Rapid Test is included in the CDC’s two-step testing algorithm for concluding evidence of prior acute dengue virus infection prior to vaccination with Sanofi’s Dengvaxia Dengue vaccine. In the United States, Dengvaxia is available for use in children and adolescents 9–16 years old with laboratory-confirmed previous dengue virus infection.... Read Full Article >
CTK’s goal during the current COVID-19 pandemic is to provide quality diagnostic tools for the detection of SARS-CoV-2, such as the Aridia Real-Time COVID-19 PCR Test. As new SARS-CoV-2 variants are identified, CTK has been working on confirmation studies to ensure that the performance of the Aridia COVID-19 Real-Time PCR Test isn’t affected by these mutations. The Aridia COVID-19 Real-Time.... Read Full Article >
As more and more variants are emerging, CTK’s commitment to ensure that CTK’s OnSite® COVID-19 Ag Rapid Test isn’t affected by these mutations is ongoing. We analyzed the NP mutations present in the California, Nigeria, and India/Delta variants and mapped them on the SARS-CoV-2 NP protein recognized by CTK’s OnSite® COVID-19 Ag Rapid Test using ELISA and peptide scanning. We found that.... Read Full Article >
The United Kingdom has identified a new coronavirus variant linked to a recent surge in cases in England. The new variant shows some mutations within the Spike protein (S-protein) as well as the NP protein. As scientists do more research to understand these mutations better, at the moment, CTK has no reason to believe that the mutations will affect.... Read Full Article >
The performance of the OnSite® COVID-19 Ag Rapid Test by CTK was evaluated using sample material from nasopharyngeal swabs stored in viral transport media. The swabs were previously used to screen for SARS-CoV-2 using qPCR. The OnSite® COVID-19 Ag Rapid Test sensitivity was between 86-90% depending on the viral load*. The study used leftover sample material selected from samples sent.... Read Full Article >
CTK is proud to provide a Complete COVID-19 Management Solution with the addition of our COVID-19 Antigen Rapid Test! See below for details! OnSite COVID-19 Ag Rapid Test Cat# R0182C Early diagnosis by detecting viral components within 1 week of symptoms High specificity ensures quick isolation of positive individuals Results in 15-20 minutes Doesn’t provide information on immune.... Read Full Article >
CTK’s vision is to provide quick and accurate solutions for every possible clinical scenario, and we continued to deliver on that mission with the development of our Aridia COVID-19 PCR kit for confirmation and our COVID-19 IgG/IgM Rapid Test for screening. This would not have been possible without the hard work and dedication of our employees. With our same level.... Read Full Article >
Introducing CTK Biotech’s New Immunofluorescence Analyzer and New Immunofluorescence Incubator! Accurate, flexible and user friendly! *Reach us through our website, contact your official CTK distributor, or e-mail us directly at info@ctkbiotech.com!
March is National (U.S.) Colorectal Cancer Awareness month. This year, Colorectal Cancer Awareness Month comes on the heels of a recent study by the American Cancer Society (ACS) revealing some staggering findings: People born in 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer compared to people in 1950 In 2017, the.... Read Full Article >
Last month1 we focused on children’s health worldwide, and in May we focused on women’s health. This month we will focus on men’s health . According to this WHO bulletin titled, The men’s health gap: men must be included in the global health equity agenda several issues are of note: Women are outliving men by an average of almost 6.... Read Full Article >
43% of Children Under Five at Risk of Poor Development. What Can We Do? “An estimated 43 percent—249 million—of children under five in low-and middle-income countries (LMICs) are at an elevated risk of poor development due to extreme poverty and stunting. Lancet – Advancing Early Childhood Development: from Science to Scale Recommendations to help reverse this trend include implementing low-cost.... Read Full Article >